Visceral leishmaniasis (VL) is a parasitic disease caused by Leishmania species. According to the important role of cellular immunity against VL, this study was directed to determine the frequency of −607A/C and −137G/C genotypes on promoter region of interleukin-18 gene. The study groups included 91 patients with confirmed history of VL, 106 healthy seronegative, and 79 healthy seropositive individuals. All three groups were analyzed by amplification refractory mutation system polymerase chain reaction (ARMS-PCR). The highest rate of −607/A, and −607/C alleles was observed in seronegative individuals (66/67 %) and in the patients (72/83 %). Allele frequency of −607/C is more than −607/A allele in all groups. In position of −137, frequency of −137/G allele in all groups was more than −137/C. Statistical analysis of distribution of genotypes, did not reveal any significant difference among groups. On the basis of the results, there was no significant association between VL and polymorphism of IL-18 promoter. The results of this study showed that IL-18 gene promoter polymorphisms at positions −607 and −137 are not associated with VL in East Azerbaijan, Iran.
Interleukin-18 Visceral leishmaniasis ARMS-PCR East Azerbaijan Iran
This is a preview of subscription content, log in to check access.
This project was supported by a grant from the Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences.
Conflict of interests
The authors declare that there is no conflict of interests.
Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27(5):305–318CrossRefPubMedGoogle Scholar
Fallah M, Bazmani A (2008) Association between endothelial selectin (E-Selectin) gene polymorphisms and E-selectin level with visceral leishmaniais, in an ARMS-PCR based study. Iran J Parasitol 3(4):23–31Google Scholar
Hajilooi M et al (2014) Is the polymorphism at position -1082 of IL-10 gene associated with visceral leishmaniasis? Iran J Public Health 43(8):1107–1112PubMedPubMedCentralGoogle Scholar
Hamidi M, Hajilooei M, Bazmani A (2013) Association of transforming growth factor-Î21 gene polymorphism with visceral leishmaniasis in an Iranian population. Shiraz E Med J 14(2):123–129Google Scholar
Harishankar M, Selvaraj P, Rajeswari DN, Anand SP, Narayanan PR (2007) Promoter polymorphism of IL-18 gene in pulmonary tuberculosis in South Indian population. Int J Immunogenet 34(5):317–320CrossRefPubMedGoogle Scholar
Kojima S, Nagamine Y, Hayano M, Looareesuwan S, Nakanishi K (2004) A potential role of interleukin 18 in severe falciparum malaria. Acta Trop 89(3):279–284CrossRefPubMedGoogle Scholar
Lee YJ et al (2006) Interleukin-18 promoter polymorphisms in patients with Behcet, s disease. Hum Immunol 67(10):812–818CrossRefPubMedGoogle Scholar
Leung WK et al (2006) H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population. Am J Gastroenterol 101(4):714–720CrossRefPubMedGoogle Scholar
Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2(11):845–858CrossRefPubMedGoogle Scholar
Vanloubbeeck Y, Jones DE (2004) The immunology of Leishmania infection and the implications for vaccine development. Ann N Y Acad Sci 1:267–272CrossRefGoogle Scholar
Wei X-Q, Niedbala W, Xu D, Luo Z-X, Pollock KGJ, Brewer JM (2004) Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunol Lett 94(1):35–37CrossRefPubMedGoogle Scholar